Children's National Hospital
Washington, District of Columbia, United States
Disclosure information not submitted.
ORF47-07 - Vosoritide Improves Growth in RASopathies, Aggrecan and NPR2 Deficiency: A Phase 2 Trial
Monday, June 15, 2026
2:45 PM - 3:00 PM CT